Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20128357 | 0.86 | DAO (0.32) | GABRA1GABRB2 | |
| SCHEMBL711814 | 0.78 | GABRA1 (0.38) | GABRA1GABRB2MGLLTP53SLC2A1 | |
| SCHEMBL28042079 | 0.74 | MEN1 (0.40) | GABRA1GABRB2TP53SLC2A1KDM4E | |
| SCHEMBL20497340 | 0.74 | KDM4E (0.39) | GABRA1GABRB2MGLLKDM4ETDP1 | |
| SCHEMBL7063569 | 0.73 | — | — | |
| SCHEMBL20128368 | 0.72 | — | — | |
| SCHEMBL10703200 | 0.72 | ALDH1A1 (0.41) | KDM4ETDP1LMNAALDH1A1 | |
| SCHEMBL31586785 | 0.70 | ALDH1A1 (0.38) | GABRA1GABRB2KDM4ETDP1LMNA | |
| SCHEMBL9522211 | 0.70 | CA1 (0.44) | MGLLTP53KDM4ETDP1LMNA | |
| SCHEMBL7357216 | 0.69 | ALDH1A1 (0.32) | GABRA1GABRB2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180127597-A1 | MOLD RESISTANT FORMABLE CORK | THE BOEING COMPANY (US) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127597-A1 | MOLD RESISTANT FORMABLE CORK | HEATR1, GRHPR, CBR3 | GABRA1 3252/4885GABRB2 3612/4885MGLL 3578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.